He is a dedicated clinical translational researcher with interests in both novel imaging research and genetics. He is a recipient of a K08 Award from the National Institutes of Health (NIH) and National Institute of Biomedical Imaging and Bioengineering (NIBIB) to explore the utility of whole-body RSI MR imaging in patients with high-risk/metastatic prostate cancer. His research group also uses advanced quantitative imaging tools to measure radiation effects on the brain. In the genomics space, Dr. Seibert heads UC San Diego’s participation in an international prostate cancer genetics consortium (PRACTICAL). The Seibert Lab develops and validates genetic risk models to identify men at risk of developing aggressive prostate cancer and to predict at what age they should undergo screening. He has published many articles in prominent scientific journals, including Radiology, Cancer, and the BMJ. He has presented at numerous national and international conferences and symposia.